Germany· DE-A57-f886548ec480b7de
Thilorbin
A medicinal product containing oxybuprocaine hydrochloride, fluorescein sodium, registered in Germany by Omnivision Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Oxybuprocaine Hydrochloride, Fluorescein Sodium
- Manufacturer
- Omnivision Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxybuprocaine hydrochloride, fluorescein sodium in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesALTAFLUORAltaire Pharmaceuticals Inc.
- FinlandOftan FlurekainSanten Oy
- SwitzerlandFluoresceine Oxybuprocaine SDU Faure, AugentropfenOmniVision AG
- SpainCOLIROFTA FLUOTEST 2,5 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓNAlcon Healthcare S.A.
- NorwayCombiflureSanten Oy
- SwedenOptax 1,25 mg/ml + 3 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Combiflure
- Denmark · Combiflure
- Finland · Oftan Flurekain
- Italy · Flurekain
- Luxembourg · Combiflure, Thilorbin
- Norway · Combiflure
- Portugal · Fluotest Multidose
- Sweden · Optax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e796de56-463a-40a1-ba61-554451c5f235 GET /v1/drugs/e796de56-463a-40a1-ba61-554451c5f235?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Oxybuprocaine Hydrochloride, Fluorescein Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about oxybuprocaine hydrochloride, fluorescein sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.